🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So happy to be asked to speak at this amazing meeting! Comprehensive genomic profiling is going to be key for identifying treatment options for patients, treatments that won’t work and also how to screen patients down the road!

Liquid biopsies serve as a guide to understand disease burden and we can use that information to tailor treatment. - Dr. Shantanu Banerji #2025BiomarkersConference

CGP is here to stay. Learning that we can monitor restistance and identify mutations to avoid progression is positive information for both clinicians and patients. - Dr. Thejus Jayakrishnan

Doctors need to develop relationships with patients and share as much information as they can, on alternate therapies. When this is missing, the patient loses trust in the healthcare system. - Nora Woo (Caregiver)

How much is too much information? We aim to offer hope while setting realistic expectations. Every doctor wants to do their best, but time constraints, provider shortages, and limited resources demand new ways to deliver meaningful care. - Dr. Michael Raphael

LIVE NOW! Innovative AI Based Technology in the Management of Metastatic Cancer This virtual conference is free ccran.org/ccran-biomarke… #CCRAN #ColorectalCancer #SupportEducationAdvocacy #CancerAwareness #JoinTheFight #CancerPrioritySetting #HealthAdvocacy

A patient should have their genome sequenced as early as possible, ideally at the point of diagnosis. It’s a battle against time. The earlier you receive results, the better positioned you are to enter a clinical trial when the time comes. - Megan Mahoney

LIVE NOW! Coming in ‘Hot’: The Future of Radioligand Therapies in Canada This virtual conference is free ccran.org/ccran-biomarke… #CancerSurvivorship #OncologyCare #CancerTreatment #CancerPatients #CancerCare #CancerAdvocates #CancerWarriors #CancerPrioritySetting

As patient partners, it is essential to stay informed about how these tools are developed and used. Ensuring the data is representative of all patient populations. - Cham Srinivasan (Caregiver)

LIVE NOW! The Value of Partnerships to Drive Innovation in Health Care Systems This virtual conference is free ccran.org/ccran-biomarke… #CCRAN #ColorectalCancer #SupportEducationAdvocacy #CancerAwareness #JoinTheFight #PatientAdvocacy #HealthForAll #CancerResearch

Public-private partnerships (P3s) can accelerate innovation, bring care models to market faster, align stakeholder priorities, de-risk early research, enhance knowledge translation, improve outcomes, and foster shared expertise across sectors - Gijs van Rooijen

Effective conflict-of-interest management in P3s requires clear boundaries: transparent goals, defined evaluation criteria, and safeguards at the program level to prevent undue influence and ensuring public interest - Étienne Richer Genome Canada

A great session! Genome Alberta

There is a significant need to increase awareness about CGP nationally. Targeted educational initiatives for both patients and clinicians are essential and continued research to improve the effectiveness and affordability of CGP is required. - Filomena Servidio-Italiano, CCRAN

A huge thank you to our sponsors, our patient advocacy group partners and the team at CCRAN for an amazing conference!